| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/09/1997 | EP0766693A1 Novel parasite protease genes and proteins |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/08/1997 | US5618805 19-nor-vitamin D compounds |
| 04/03/1997 | WO1997012038A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | WO1997011702A1 Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors |
| 04/03/1997 | CA2232950A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | CA2231434A1 Method of preventing androgenetic alopecia with 5-.alpha. reductase inhibitors |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765308A1 Enzyme inhibitors |
| 04/01/1997 | US5616724 Fused pyrrolo[2,3-c]carbazole-6-ones |
| 04/01/1997 | US5616574 Steroid sulphatase inhibitors |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | WO1997005875A3 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0639077B1 Drug for increasing the level of testosterone in the body |
| 03/26/1997 | EP0559751B1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 03/26/1997 | CN1146206A Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
| 03/26/1997 | CN1145783A Pharmaceutical composition |
| 03/25/1997 | US5614517 Treatment of neurological disorders influenced by gamma-aminobutyric acid receptors |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614490 Administration of low dose hemoglobin to increase perfusion |
| 03/20/1997 | WO1997010230A1 Diarylalkenylamine derivatives |
| 03/20/1997 | WO1997010217A1 4-azasteroids for treatment of hyperandrogenic conditions |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1996025498A3 Mpl ligand analogs |
| 03/20/1997 | CA2232161A1 Diarylalkenylamine derivatives |
| 03/20/1997 | CA2231041A1 4-azasteroids for treatment of hyperandrogenic conditions |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/18/1997 | US5612356 Retinoid antagonists |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/13/1997 | WO1997009297A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/13/1997 | WO1997009046A1 Compounds and methods |
| 03/13/1997 | WO1997009044A1 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/13/1997 | WO1996039372A3 Macrophage lipid chemoattractant |
| 03/13/1997 | CA2230974A1 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/12/1997 | EP0761669A2 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/12/1997 | EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments |
| 03/12/1997 | EP0422100B1 11 beta-substituted progesterone analogs |
| 03/11/1997 | US5610136 Administering chorionic gonadotropin |
| 03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | WO1997008145A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | WO1997007789A1 Regulation of intracellular glucocorticoid concentrations |
| 03/06/1997 | CA2230209A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/05/1997 | CN1144486A Treatment of ovarian estrogen dependent conditions |
| 03/05/1997 | CN1144120A Traditional Chinese medicine antagonist for adrenocortical hormone adverse reaction and compound preparation thereof |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997006796A1 Benzothiophene compounds |
| 02/27/1997 | WO1997006793A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | CA2229554A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/26/1997 | EP0759434A1 Benzothiophene compounds |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143628A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605702 Eva-based transdermal matrix system for the administration of an estrogen and/or a progestogen |
| 02/20/1997 | WO1997006168A1 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives |
| 02/20/1997 | WO1997006136A1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 02/20/1997 | WO1997005875A2 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 02/20/1997 | WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | WO1996040757A3 Lhrh antagonist peptides |
| 02/20/1997 | CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2227912A1 Benzenesulphonamide derivatives, their preparation and their application in therapy |
| 02/20/1997 | CA2221241A1 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 02/20/1997 | CA2213773A1 Imidazopyridine derivatives |
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/13/1997 | WO1997005167A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | WO1997004784A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 02/13/1997 | WO1997004778A1 Pyridine compounds, intermediates, processes, compositions, and methods |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | WO1997004760A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | CA2227980A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | CA2227877A1 Pyridine compounds, intermediates, processes, compositions, and methods |
| 02/13/1997 | CA2224293A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/12/1997 | EP0757681A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | CA1338906C 11 beta-substituted progesterone analogs |
| 02/06/1997 | WO1997003686A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | WO1997003682A1 Method for treating cancers using 6-[3-[1-adamantyl]-4-hydroxyphenyl] |
| 02/06/1997 | WO1997003677A1 Inhibition of nmda receptor activity by pregnenolone sulfate derivatives |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003629A1 Drug delivery compositions for improved stability of steroids |
| 02/06/1997 | CA2223489A1 Method for treating cancer using ahpn |
| 02/05/1997 | EP0756599A1 Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
| 02/05/1997 | CN1142227A Novel thiazolidin-4-one derivatives |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1141926A Preparation of intermediat of 19, 11 beta-bridge steroid |
| 02/05/1997 | CN1033975C Preparation of 2beta, 19-ethylene bridged steroids as aromatase inhibitors |
| 01/30/1997 | WO1997002834A1 Analogs of parathyroid hormone |